A randomized phase II study comparing consolidation with a single dose of
Antibodies, Monoclonal
Antibodies, Monoclonal, Murine-Derived
/ therapeutic use
Antineoplastic Combined Chemotherapy Protocols
/ adverse effects
Disease-Free Survival
Follow-Up Studies
Humans
Lymphoma, Follicular
/ diagnosis
Radioimmunotherapy
/ methods
Rituximab
/ adverse effects
Treatment Outcome
Yttrium Radioisotopes
/ therapeutic use
90Y ibritumomab tiuxetan
Follicular lymphoma
maintenance
Journal
Leukemia & lymphoma
ISSN: 1029-2403
Titre abrégé: Leuk Lymphoma
Pays: United States
ID NLM: 9007422
Informations de publication
Date de publication:
01 2022
01 2022
Historique:
pubmed:
31
8
2021
medline:
8
3
2022
entrez:
30
8
2021
Statut:
ppublish
Résumé
This is a randomized phase-2 trial aimed to compare consolidation vs. maintenance in untreated patients with follicular lymphoma (FL) responding to induction. 146 patients were enrolled from 25 Spanish institutions (ZAR2007; ClinicalTrials.gov #NCT00662948). Patients in PR or CR/CR[u] after R-CHOP were randomized 1:1 to
Identifiants
pubmed: 34459702
doi: 10.1080/10428194.2021.1971216
doi:
Substances chimiques
Antibodies, Monoclonal
0
Antibodies, Monoclonal, Murine-Derived
0
Yttrium Radioisotopes
0
Rituximab
4F4X42SYQ6
ibritumomab tiuxetan
4Q52C550XK
Banques de données
ClinicalTrials.gov
['NCT00662948']
Types de publication
Clinical Trial, Phase II
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM